| |
| |
|
| Insider
Information: |
Mazzo David J |
| Relationship: |
Chief Executive Office... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
711,243 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$163,057 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
711,243 |
|
|
| Total
Value |
$163,057 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Avanir Pharmaceuticals |
AVNR |
Director |
2014-02-12 |
336,394 |
2006-02-13 |
0 |
Premium* |
|
|
EyePoint Pharmaceuticals Inc |
EYPT |
|
2019-10-09 |
200,083 |
|
0 |
Premium* |
|
|
Lisata Therapeutics Ord Shs |
LSTA |
Chief Executive Office... |
2024-01-11 |
174,766 |
2015-01-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AVNR |
Avanir Pharmaceuticals |
Director |
– • – |
2006-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
6,435 |
6,435 |
|
- |
|
| AVNR |
Avanir Pharmaceuticals |
officerTitle |
– • – |
2007-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
44,248 |
51,683 |
0 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
Director |
– • – |
2008-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
56,911 |
108,594 |
0 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
Director |
– • – |
2009-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
168,594 |
0 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
Director |
– • – |
2010-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
208,594 |
0 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
Director |
– • – |
2011-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
238,594 |
0 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
Director |
– • – |
2012-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
268,594 |
0 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
Director |
– • – |
2013-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
38,900 |
307,494 |
0 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
Director |
– • – |
2014-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
28,900 |
336,394 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2015-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
290,078 |
290,078 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2015-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
239,543 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2016-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
212,800 |
484,478 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2017-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
33,300 |
80,538 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2018-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
33,300 |
96,706 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2018-06-20 |
4 |
A |
$8.64 |
$287,712 |
D/D |
33,300 |
125,544 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2019-01-14 |
4 |
A |
$0.00 |
$0 |
D/D |
47,000 |
157,706 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2021-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
119,000 |
311,274 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2021-01-13 |
4 |
A |
$0.00 |
$0 |
D/D |
39,000 |
333,653 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2022-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
401,000 |
717,297 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2022-09-01 |
4 |
A |
$0.50 |
$75,000 |
D/D |
150,000 |
809,186 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2023-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
109,285 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2024-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
94,000 |
199,308 |
0 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
Director |
– • – |
2006-02-14 |
4 |
B |
$15.59 |
$15,590 |
D/D |
1,000 |
7,435 |
2.39 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2015-08-17 |
4 |
B |
$1.40 |
$27,922 |
D/D |
20,000 |
259,543 |
2.81 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2015-01-16 |
4 |
D |
$3.48 |
$454,262 |
D/D |
(130,535) |
159,543 |
0 |
- |
|
62 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
